Compare Stocks

EOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil, natural gas liquids, and natural gas primarily in producing basins in the United States, the Republic of Trinidad and Tobago and internationally. The company was formerly known as Enron Oil & Gas Company. EOG Resources, Inc. was incorporated in 1985 and is headquartered in Houston, Texas.

Falcon Oil & Gas Ltd., an oil and gas company, engages in the exploration, and development of unconventional oil and gas assets in Australia, South Africa, and Hungary. The company holds 22.5% interests in three exploration permits covering an area of approximately 1 million net acres in the Beetaloo Sub-basin, Northern Territory, Australia. It also holds a 100% interest in the technical cooperation permit covering an area of approximately 30,327.9 square kilometers in the southwest Karoo Basin, South Africa; and a 100% interest in the Makó production license covering an area of approximately 994.6 square kilometers in the Makó Trough located in south-eastern Hungary. The company was incorporated in 1980 and is headquartered in Dublin, Ireland.

CGX Energy Inc., an oil and gas exploration company, explores for and evaluates petroleum and natural gas properties in Guyana, South America. It holds interests in three petroleum prospecting licenses and related petroleum agreements, including Corentyne, Berbice, and Demerara blocks located in offshore and onshore Guyana. The company also constructs and develops the Berbice Deep Water Port project in Guyana. CGX Energy Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Storm Resources Ltd. operates as a crude oil and natural gas exploration and development company in Canada. The company primarily owns interests in lands covering an area of 120,000 net acres located in Umbach, Nig Creek, and Fireweed areas of Northeast British Columbia. As of December 31, 2020, it had 49,134 thousand barrels of oil equivalent of total proved plus probable reserves. Storm Resources Ltd. was incorporated in 2010 and is headquartered in Calgary, Canada.